Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curanosticum Wiesbaden-Frankfurt (Curanosticum MVZ GmbH) is a leading German medical care center specializing in nuclear medicine, molecular imaging, and theranostics. Operating sites in Wiesbaden and Frankfurt, the clinic combines advanced PET/CT diagnostics with molecular radiotherapies to provide personalized cancer care. Curanosticum is a pioneer in theranostics, offering state-of-the-art diagnostic imaging and targeted radiomolecular therapies for indications such as prostate cancer and neuroendocrine tumors. In early 2023, the company was acquired by the RAD-x Group, expanding its network of high-end nuclear medicine and radiology clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curanosticum Wiesbaden-Frankfurt.